PL89025B1 - - Google Patents

Download PDF

Info

Publication number
PL89025B1
PL89025B1 PL15741472A PL15741472A PL89025B1 PL 89025 B1 PL89025 B1 PL 89025B1 PL 15741472 A PL15741472 A PL 15741472A PL 15741472 A PL15741472 A PL 15741472A PL 89025 B1 PL89025 B1 PL 89025B1
Authority
PL
Poland
Prior art keywords
weight
solution
parts
nitrophenyl
sublingually
Prior art date
Application number
PL15741472A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL89025B1 publication Critical patent/PL89025B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
PL15741472A 1972-02-29 1972-08-23 PL89025B1 ( )

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722209526 DE2209526C3 (de) 1972-02-29 1972-02-29 Coronartherapeutlkum in Form von Gelatine-BeiBkapseln

Publications (1)

Publication Number Publication Date
PL89025B1 true PL89025B1 ( ) 1976-10-30

Family

ID=5837426

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15741472A PL89025B1 ( ) 1972-02-29 1972-08-23

Country Status (4)

Country Link
AT (1) AT328073B ( )
CS (1) CS199202B2 ( )
DE (1) DE2209526C3 ( )
PL (1) PL89025B1 ( )

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3526546A1 (de) * 1985-07-25 1987-01-29 Scherer Gmbh R P Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel

Also Published As

Publication number Publication date
DE2209526B2 (de) 1979-06-28
DE2209526C3 (de) 1980-02-28
CS199202B2 (en) 1980-07-31
DE2209526A1 (de) 1973-09-06
AT328073B (de) 1976-03-10
ATA723072A (de) 1975-05-15

Similar Documents

Publication Publication Date Title
US3784684A (en) Coronary dilator in a pharmaceutical dosage unit form
US5472002A (en) Cigarette filter for administering taurine by inhalation
US5397574A (en) Controlled release potassium dosage form
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
US5108750A (en) Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
PL89025B1 ( )
SE8300577D0 (sv) Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad ....
DE4018919C2 (de) Nitroglycerin-Spray
US4906471A (en) Pharmaceutical composition for the reducing both hyperlipidemia and platelet-aggregation (PHP)
JPS5632418A (en) Antithrombic agent containing crude drug
JPS57149217A (en) Slow-releasing pharmaceutical preparation
Jonkman et al. Variations in the bioavailability of thiazinamium methylsulfate
CN101491519B (zh) 一种银杏内酯注射剂及其制备方法
JPS6137731A (ja) グアバ葉エキスを有効成分とする経口糖尿病薬
IE38614B1 (en) Orally administrable corticosteroid preparations
PT94823A (pt) Novo processo de controle da biodisponibilidade de um medicamento oral
US4220636A (en) Stabilized suppositories containing ergo-alkaloids
JPS5569510A (en) Carcinostatic agent
Fann et al. Halazepam in the treatment of recurrent anxiety attacks in chronically anxious outpatients: A double-blind placebo controlled study.
O'Grady et al. Influence of soft gelatin on digoxin absorption.
JPH08208464A (ja) 高脂血症の治療及び予防薬
KR900017583A (ko) 경구용 진해 조성물
DIETZEL et al. The prophylactic effect of Innovar® in experimental hemorrhagic shock
Hjalmarson Sinus node inhibitors